Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,350 | -29,343 | -14,604 | -35,434 | -24,686 |
| Depreciation Amortization | -1,289 | -694 | -270 | -230 | -50 |
| Accounts receivable | -16 | -14 | -41 | 79 | 86 |
| Other Working Capital | 90 | 65 | -213 | 2,560 | 608 |
| Other Operating Activity | 7,121 | 4,543 | 2,277 | 4,584 | 3,075 |
| Operating Cash Flow | $-38,444 | $-25,443 | $-12,851 | $-28,441 | $-20,967 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,918 | -25,857 | -29,714 | -23,418 | -19,327 |
| Investing Cash Flow | $-83,918 | $-25,857 | $-29,714 | $-23,418 | $-19,327 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,000 | -250 | N/A | N/A | N/A |
| Common Stock Issued | 132,497 | 57,775 | 57,650 | 53,911 | 53,905 |
| Other Financing Activity | 0 | 0 | 0 | -344 | 0 |
| Financing Cash Flow | $131,497 | $57,525 | $57,650 | $53,567 | $53,905 |
| Beginning Cash Position | 11,433 | 11,433 | 11,433 | 9,725 | 9,725 |
| End Cash Position | 20,568 | 17,658 | 26,518 | 11,433 | 23,336 |
| Net Cash Flow | $9,135 | $6,225 | $15,085 | $1,708 | $13,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,444 | -25,443 | -12,851 | -28,441 | -20,967 |
| Free Cash Flow | -38,444 | -25,443 | -12,851 | -28,441 | -20,967 |